NM_000160.5:c.118G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000160.5(GCGR):​c.118G>A​(p.Gly40Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00808 in 1,536,594 control chromosomes in the GnomAD database, including 84 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0064 ( 13 hom., cov: 33)
Exomes 𝑓: 0.0083 ( 71 hom. )

Consequence

GCGR
NM_000160.5 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.712

Publications

54 publications found
Variant links:
Genes affected
GCGR (HGNC:4192): (glucagon receptor) The protein encoded by this gene is a glucagon receptor that is important in controlling blood glucose levels. Defects in this gene are a cause of non-insulin-dependent diabetes mellitus (NIDDM).[provided by RefSeq, Jan 2010]
GCGR Gene-Disease associations (from GenCC):
  • GCGR-related hyperglucagonemia
    Inheritance: AR, Unknown Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.02872321).
BP6
Variant 17-81809839-G-A is Benign according to our data. Variant chr17-81809839-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 16159.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00826 (11438/1384256) while in subpopulation MID AF = 0.0372 (212/5696). AF 95% confidence interval is 0.0331. There are 71 homozygotes in GnomAdExome4. There are 5560 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GCGRNM_000160.5 linkc.118G>A p.Gly40Ser missense_variant Exon 3 of 14 ENST00000400723.8 NP_000151.1
GCGRXM_006722277.2 linkc.118G>A p.Gly40Ser missense_variant Exon 3 of 14 XP_006722340.1
GCGRXM_017024446.2 linkc.112G>A p.Gly38Ser missense_variant Exon 3 of 14 XP_016879935.1
GCGRXM_011523539.2 linkc.-109G>A 5_prime_UTR_variant Exon 1 of 12 XP_011521841.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GCGRENST00000400723.8 linkc.118G>A p.Gly40Ser missense_variant Exon 3 of 14 1 NM_000160.5 ENSP00000383558.3

Frequencies

GnomAD3 genomes
AF:
0.00646
AC:
983
AN:
152220
Hom.:
14
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00193
Gnomad AMI
AF:
0.125
Gnomad AMR
AF:
0.00857
Gnomad ASJ
AF:
0.0147
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00477
Gnomad FIN
AF:
0.000847
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.00795
Gnomad OTH
AF:
0.00957
GnomAD2 exomes
AF:
0.00740
AC:
1049
AN:
141720
AF XY:
0.00753
show subpopulations
Gnomad AFR exome
AF:
0.00225
Gnomad AMR exome
AF:
0.00679
Gnomad ASJ exome
AF:
0.0119
Gnomad EAS exome
AF:
0.0000942
Gnomad FIN exome
AF:
0.00185
Gnomad NFE exome
AF:
0.00855
Gnomad OTH exome
AF:
0.00972
GnomAD4 exome
AF:
0.00826
AC:
11438
AN:
1384256
Hom.:
71
Cov.:
32
AF XY:
0.00814
AC XY:
5560
AN XY:
683062
show subpopulations
African (AFR)
AF:
0.00222
AC:
70
AN:
31594
American (AMR)
AF:
0.00681
AC:
243
AN:
35700
Ashkenazi Jewish (ASJ)
AF:
0.0119
AC:
299
AN:
25182
East Asian (EAS)
AF:
0.0000840
AC:
3
AN:
35734
South Asian (SAS)
AF:
0.00775
AC:
614
AN:
79234
European-Finnish (FIN)
AF:
0.00137
AC:
47
AN:
34366
Middle Eastern (MID)
AF:
0.0372
AC:
212
AN:
5696
European-Non Finnish (NFE)
AF:
0.00871
AC:
9401
AN:
1078842
Other (OTH)
AF:
0.00948
AC:
549
AN:
57908
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
629
1258
1887
2516
3145
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
382
764
1146
1528
1910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00645
AC:
982
AN:
152338
Hom.:
13
Cov.:
33
AF XY:
0.00614
AC XY:
457
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00195
AC:
81
AN:
41578
American (AMR)
AF:
0.00856
AC:
131
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0147
AC:
51
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5192
South Asian (SAS)
AF:
0.00477
AC:
23
AN:
4822
European-Finnish (FIN)
AF:
0.000847
AC:
9
AN:
10620
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.00795
AC:
541
AN:
68032
Other (OTH)
AF:
0.00947
AC:
20
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
50
101
151
202
252
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00819
Hom.:
18
Bravo
AF:
0.00759
TwinsUK
AF:
0.00809
AC:
30
ALSPAC
AF:
0.00960
AC:
37
ESP6500AA
AF:
0.000723
AC:
1
ESP6500EA
AF:
0.0113
AC:
36
ExAC
AF:
0.00582
AC:
142
Asia WGS
AF:
0.00462
AC:
16
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Dec 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GCGR: BP4, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Type 2 diabetes mellitus Benign:1
Feb 01, 1996
OMIM
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
2.4
DANN
Benign
0.88
DEOGEN2
Benign
0.034
T;.;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.020
N
LIST_S2
Benign
0.28
T;T;T
MetaRNN
Benign
0.029
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.61
N;.;.
PhyloP100
0.71
PrimateAI
Benign
0.37
T
PROVEAN
Benign
1.4
N;.;.
REVEL
Benign
0.028
Sift
Benign
0.38
T;.;.
Sift4G
Benign
0.42
T;T;T
Polyphen
0.0010
B;.;.
Vest4
0.10
MVP
0.43
MPC
0.0026
ClinPred
0.00042
T
GERP RS
-1.3
Varity_R
0.10
gMVP
0.67
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1801483; hg19: chr17-79767715; COSMIC: COSV105339528; COSMIC: COSV105339528; API